Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04270617
Other study ID # 19-00824
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 1, 2019
Est. completion date January 1, 2026

Study information

Verified date November 2023
Source NYU Langone Health
Contact Erich Anderer, MD
Phone (718) 630-6580
Email erich.anderer@nyulangone.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic low back pain is notoriously difficult to treat and is a primary contributor to lost work days and excessive health expenditures, and whose treatment has, in part, contributed to the opioid crisis. Surgery is only an option in a minority of these patients, usually confined to those with structural instability. Yoga is an ancient modality whose benefits are currently being studied.


Description:

The purpose of this research study is to determine whether a 6 week standardized yoga practice is superior to usual conservative therapies in the treatment of chronic back pain at 6 months. There is enough data that the most recent ACP guidelines have included yoga as a treatment for chronic back pain, but more data needs to be generated regarding the efficacy of this modality in treating the chronic back pain population.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date January 1, 2026
Est. primary completion date January 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Willingness to and ability to participate in study procedures - Chronic back pain (pain above the gluteal cleft of at least 3 months duration) Exclusion Criteria: - Indication for surgery (i.e., fracture, infection, scoliosis, spondylolisthesis) - Cardiac, pulmonary or other medical comorbidities that preclude participation in yoga practice

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Yoga program
The intervention will be a 6-week ashtanga yoga program designed by world-renowned yogi Eddie Stern. Eddie Stern is an internationally known Ashtanga yoga teacher, in independent practice not affiliated with NYULH, who has done significant work exploring the physiology and science of yoga. He is not currently engaged in his own research. The yoga protocol for chronic back pain was designed with poses specific to addressing core strength but are gentle enough for patients in pain. The protocol is designed to be directed by a teacher initially but can be done at home and is only 18 minutes in duration.

Locations

Country Name City State
United States NYULangone New York New York

Sponsors (1)

Lead Sponsor Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in VAS(visual analog scale) The visual analogue scale or visual analog scale (VAS) is designed to measure pain intensity with less pain being experienced by those in the intervention group in comparison to the control group. Enrollment visit, 6 months after enrollment visit
Primary Changes in ODI (Oswestry Disability Index) The Oswestry Disability Index (ODI) is an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain. Improvement will be measured by the lower score out of a 100, which reflects less disability. Enrollment visit, 6 months after enrollment visit
Primary Changes in SF-36 (Short Form (36) Health Survey ) The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. Improvement with those with Yoga will be seen by higher scores in SF-36 which indicate lower disability. Enrollment visit, 6 months after enrollment visit
Secondary Long term changes in VAS after intervention The visual analogue scale or visual analog scale (VAS) is designed to measure pain intensity with less pain being experienced by those in the intervention group in comparison to the control group. Baseline Visit, 6 weeks Visit , 3 months Visit , 1 year Visit , 2 years Visit
Secondary Long term changes in ODI after intervention The Oswestry Disability Index (ODI) is an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain. Improvement will be measured by the lower score out of a 100, which reflects less disability. Baseline Visit, 6 weeks Visit , 3 months Visit , 1 year Visit , 2 years Visit
Secondary Long term changes in SF-36 after intervention The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. Improvement with those with Yoga will be seen by higher scores in SF-36 which indicate lower disability. Baseline Visit, 6 weeks Visit , 3 months Visit , 1 year Visit , 2 years Visit
See also
  Status Clinical Trial Phase
Completed NCT01944150 - Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis N/A
Recruiting NCT05220202 - MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression N/A
Completed NCT04571242 - SCS Programming Study in Treating Intractable Chronic Back Pain (NOVA) N/A
Active, not recruiting NCT05203770 - Adaptations of the Brain in Chronic Pain With Opioid Exposure I
Withdrawn NCT04082715 - Transition From Acute to Chronic Back Pain : Effect of L-dopa,Gender,and Associated Brain Plasticity Phase 2
Completed NCT04307446 - Immersive Virtual Reality and Chronic Back Pain N/A
Completed NCT03896035 - Improving Outcomes for Older Veterans With Chronic Back Pain and Depression N/A
Recruiting NCT05994118 - Physiological, Cognitive, and Personal Features in the Link Between Placebo-effect and Variability of Pain Reports N/A
Active, not recruiting NCT03312010 - Tsunami DRG High Frequency Stimulation Study N/A
Completed NCT05167214 - The Acute Effect Of Different Kinesiological Tape N/A
Recruiting NCT06288282 - Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain
Withdrawn NCT01631513 - An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR) Phase 4
Completed NCT01766973 - Decoding Chronic Pain With fMRI
Completed NCT02375633 - Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients Phase 3
Recruiting NCT06406699 - Feasibility and Acceptability of Group Pain Reprocessing Therapy for Veterans With Chronic Neck/Back Pain N/A